Millennium Management
IGC icon

Millennium Management’s IGC Pharma IGC Stock Holding History

Millennium Management’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,276
Closed -$5.13K – 6277
2023
Q3 		$5.13K Buy
14,276
+984
+7% +$352 ﹤0.01% 5877
2023
Q2 		$4.14K Sell
13,292
-90,491
-87% -$29.3K ﹤0.01% 5883
2023
Q1 		$35K Sell
103,783
-40,941
-28% -$15.4K ﹤0.01% 5728
2022
Q4 		$46K Buy
144,724
+62,599
+76% +$25.5K ﹤0.01% 5800
2022
Q3 		$35K Buy
+82,125
New +$43.8K ﹤0.01% 6295
2021
Q1 		– Sell
-17,874
Closed -$28K – 6195
2020
Q4 		$28K Buy
+17,874
New +$26.4K ﹤0.01% 5121

Other funds holding IGC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Millennium Management's IGC Position: Q4 2023 in Review

Millennium Management sold out of IGC Pharma (IGC) in Q4 2023, closing a stake of 14,276 shares — an estimated $5.13K sold.

Millennium Management first reported a position in IGC in Q4 2020 and held it in 6 quarters. The position peaked at $46K in Q4 2022. 25 funds tracked by Wall St. Rank hold IGC as of Q4 2023.

  • Millennium Management reported no remaining IGC Pharma position as of Q4 2023 after selling out during the quarter.
  • Millennium Management sold 14,276 IGC Pharma shares in Q4 2023, an estimated $5.13K.
  • Millennium Management first reported a position in IGC Pharma in Q4 2020 and held it in 6 quarters.
  • Millennium Management's IGC Pharma position peaked at $46K in Q4 2022.
  • 25 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.